Abstract
Background: Use of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in non-valvular atrial fibrillation (NVAF) is common and......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
